Mark E. Sherman

95.8k total citations · 3 hit papers
322 papers, 19.4k citations indexed

About

Mark E. Sherman is a scholar working on Epidemiology, Oncology and Cancer Research. According to data from OpenAlex, Mark E. Sherman has authored 322 papers receiving a total of 19.4k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Epidemiology, 94 papers in Oncology and 70 papers in Cancer Research. Recurrent topics in Mark E. Sherman's work include Cervical Cancer and HPV Research (90 papers), Endometrial and Cervical Cancer Treatments (60 papers) and Ovarian cancer diagnosis and treatment (49 papers). Mark E. Sherman is often cited by papers focused on Cervical Cancer and HPV Research (90 papers), Endometrial and Cervical Cancer Treatments (60 papers) and Ovarian cancer diagnosis and treatment (49 papers). Mark E. Sherman collaborates with scholars based in United States, Costa Rica and Netherlands. Mark E. Sherman's co-authors include Mark Schiffman, M. Michele Manos, R. J. Kurman, Robert J. Kurman, Allan Hildesheim, Sholom Wacholder, Keshu Shan, F. Xavier Bosch, Vı́ctor Moreno and J Peto and has published in prestigious journals such as JAMA, Circulation and Journal of Clinical Oncology.

In The Last Decade

Mark E. Sherman

308 papers receiving 18.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective

1995 2.8k citations Mark E. Sherman, Mark Schiffman et al. profile →
Epidemiologic Evidence Showing That Human Papillomavirus Infection Causes Most Cervical Intraepithelial Neoplasia

1993 986 citations Mark Schiffman, Mark E. Sherman et al. profile →
Persistence of Type-Specific Human Papillomavirus Infection among Cytologically Normal Women

1994 581 citations Allan Hildesheim, Mark Schiffman et al. profile →

Peers

Countries citing papers authored by Mark E. Sherman

Since Specialization

Citations

This map shows the geographic impact of Mark E. Sherman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Sherman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Sherman more than expected).

Fields of papers citing papers by Mark E. Sherman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. Sherman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Sherman. The network helps show where Mark E. Sherman may publish in the future.

Co-authorship network of co-authors of Mark E. Sherman

This figure shows the co-authorship network connecting the top 25 collaborators of Mark E. Sherman. A scholar is included among the top collaborators of Mark E. Sherman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark E. Sherman. Mark E. Sherman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Determinants of Hemodynamic Response and Complication Rates in Pulmonary Embolism Patients Undergoing Percutaneous Mechanical Embolectomy: Insights From a Large Single-center Retrospective Study 2025 ·American Journal of Respiratory and Critical Care Medicine ·(unknown), (unknown), Mark E. Sherman, (unknown), (unknown), Laura Gutiérrez, (unknown), A Henning, (unknown), (unknown), (unknown), (unknown), Adeel Nasrullah	0
2	Highly pathogenic avian influenza A H5N1 virus infection in an immunocompromised domestic cat 2025 ·PubMed ·Chi Chen, (unknown), (unknown), (unknown), Colleen Olmstead, (unknown), Mark E. Sherman, Herman Yee, (unknown), Martha A. Delaney, Miranda D. Vieson, Yīng Fāng	0
3	424 Deciphering the Immune Landscape in Benign Breast Disease: Implications for Risk Stratification and Breast Cancer Prevention 2024 ·Journal of Clinical and Translational Science ·(unknown), (unknown), (unknown), Amy C. Degnim, Mark E. Sherman, Derek C. Radisky	0
4	Understanding Benign Breast Disease and Subsequent Breast Cancer in Hispanic White Females: A Step Closer to Evidence-Based Management 2024 ·Cancer Epidemiology Biomarkers & Prevention ·(unknown), Andrea M. Nibbe, Robert A. Vierkant, (unknown), Lisa R. Seymour, Celine M. Vachon, Mark E. Sherman, Stacey J. Winham, Amy C. Degnim, Deirdre A. Hill	0
5	Methylated DNA Markers for Sporadic Colorectal and Endometrial Cancer Are Strongly Associated with Lynch Syndrome Cancers 2023 ·Cancer Prevention Research ·(unknown), Jamie N. Bakkum‐Gamez, Seth W. Slettedahl, Patrick H. Foote, (unknown), Calise K. Berger, (unknown), (unknown), Longwen Chen, (unknown), Kelli N. Burger, Douglas W. Mahoney, Mark E. Sherman, John B. Kisiel, (unknown)	3
6	DNA barcoded competitive clone-initiating cell analysis reveals novel features of metastatic growth in a cancer xenograft model 2022 ·NAR Cancer ·(unknown), Xiaojia Tang, Jianning Song, Upasana Ray, Stephen J. Russell, S. John Weroha, Jamie N. Bakkum‐Gamez, Viji Shridhar, Mark E. Sherman, Connie J. Eaves, David J. H. F. Knapp, Krishna R. Kalari, Nagarajan Kannan	1
7	Molecular and Clinical Characterization of Postpartum-Associated Breast Cancer in the Carolina Breast Cancer Study Phase I–III, 1993–2013 2021 ·Cancer Epidemiology Biomarkers & Prevention ·(unknown), Andrea Walens, Alina M. Hamilton, Mark E. Sherman, Pepper Schedin, Hazel B. Nichols, Katherine E. Reeder‐Hayes, Andrew F. Olshan, Michael I. Love, Melissa A. Troester	2
8	Sex Hormones, Insulin, and Insulin-like Growth Factors in Recurrence of High-Stage Endometrial Cancer 2021 ·Cancer Epidemiology Biomarkers & Prevention ·Melissa A. Merritt, Howard D. Strickler, Alan D. Hutson, Mark H. Einstein, Thomas E. Rohan, Xiaonan Xue, Mark E. Sherman, Louise A. Brinton, Herbert Yu, David S. Miller, Nilsa C. Ramirez, Heather A. Lankes, Michael J. Birrer, Gloria S. Huang, Marc J. Gunter	10
9	Breast Cancer Risk and Use of Nonsteroidal Anti-inflammatory Agents After a Benign Breast Biopsy 2020 ·Cancer Prevention Research ·Mark E. Sherman, Robert A. Vierkant, (unknown), Tanya L. Hoskin, Marlene H. Frost, (unknown), Daniel W. Visscher, Jodi M. Carter, Stacey J. Winham, Matthew R. Jensen, Derek C. Radisky, Celine M. Vachon, Amy C. Degnim	9
10	Relationship of Serum Progesterone and Progesterone Metabolites with Mammographic Breast Density and Terminal Ductal Lobular Unit Involution among Women Undergoing Diagnostic Breast Biopsy 2020 ·Journal of Clinical Medicine ·(unknown), Hannah Oh, Shaoqi Fan, Roni T. Falk, Berta M. Geller, Pamela M. Vacek, Donald L. Weaver, John Shepherd, Jeff Wang, Bo Fan, Sally D. Herschorn, Louise A. Brinton, Xia Xu, Mark E. Sherman, Britton Trabert, Gretchen L. Gierach	7
11	Potent immunomodulatory effects of an anti-CEA-IL-2 immunocytokine on tumor therapy and effects of stereotactic radiation 2020 ·OncoImmunology ·Maciej Kujawski, Mark E. Sherman, Susanta Hui, (unknown), Wen‐Hwa Lee, Paul J. Yazaki, (unknown), Barbara K. Szpikowska, Junie Chea, (unknown), (unknown), (unknown), David Colcher, Jeffrey Y.C. Wong, John E. Shively	17
12	Immune Responses and Risk of Triple-negative Breast Cancer: Implications for Higher Rates among African American Women 2020 ·Cancer Prevention Research ·Joshua Ogony, Derek C. Radisky, Kathryn J. Ruddy, Steven Goodison, Daniel P. Wickland, Kathleen M. Egan, Keith L. Knutson, Yan W. Asmann, Mark E. Sherman	10
13	Using Digital Pathology to Understand Epithelial Characteristics of Benign Breast Disease among Women Undergoing Diagnostic Image-Guided Breast Biopsy 2019 ·Cancer Prevention Research ·Maeve Mullooly, (unknown), Shaoqi Fan, Ruth M. Pfeiffer, (unknown), (unknown), Erin L. Kirk, Pamela M. Vacek, Donald L. Weaver, John Shepherd, Amir Pasha Mahmoudzadeh, Jeff Wang, Serghei Malkov, Jason M. Johnson, Stephen M. Hewitt, Sally D. Herschorn, Mark E. Sherman, Melissa A. Troester, Gretchen L. Gierach	1
14	Learning to detect lymphocytes in immunohistochemistry with deep learning 2019 ·Medical Image Analysis ·Żaneta Świderska-Chadaj, Hans Pinckaers, Mart van Rijthoven, Maschenka Balkenhol, (unknown), Oscar Geessink, Quirine F. Manson, Mark E. Sherman, António Polónia, (unknown), Mustapha Abubakar, Geert Litjens, Jeroen van der Laak, Francesco Ciompi	104
15	Longitudinal Change in Mammographic Density among ER-Positive Breast Cancer Patients Using Tamoxifen 2015 ·Cancer Epidemiology Biomarkers & Prevention ·Sarah J. Nyante, Mark E. Sherman, Ruth M. Pfeiffer, Amy Berrington de González, Louise A. Brinton, Erin J. Aiello Bowles, Robert N. Hoover, Andrew G. Glass, Gretchen L. Gierach	20
16	Circulating Sex Hormones and Terminal Duct Lobular Unit Involution of the Normal Breast 2014 ·Cancer Epidemiology Biomarkers & Prevention ·Zeina G. Khodr, Mark E. Sherman, Ruth M. Pfeiffer, Gretchen L. Gierach, Louise A. Brinton, Roni T. Falk, Deesha A. Patel, (unknown), (unknown), Susan E. Clare, Daniel W. Visscher, Carolyn Mies, Stephen M. Hewitt, Anna Maria Storniolo, (unknown), Jesus J. Caban, Jonine D. Figueroa	18
17	Comparison of Mammographic Density Assessed as Volumes and Areas among Women Undergoing Diagnostic Image-Guided Breast Biopsy 2014 ·Cancer Epidemiology Biomarkers & Prevention ·Gretchen L. Gierach, Berta M. Geller, John Shepherd, Deesha A. Patel, Pamela M. Vacek, Donald L. Weaver, (unknown), Ruth M. Pfeiffer, Bo Fan, Amir Pasha Mahmoudzadeh, Jeff Wang, Jason M. Johnson, Sally D. Herschorn, Louise A. Brinton, Mark E. Sherman	15
18	Description of a seven-year prospective study of human papillomavirus infection and cervical neoplasia among 10 000 women in Guanacaste, Costa Rica Descripción de un estudio prospectivo de siete años sobre la infección por el virus del papiloma humano y el cáncer cervicouterino en 10 000 mujeres de Guanacaste, Costa Rica 2004 ·SHILAP Revista de lepidopterología ·M. Concepción Bratti, Ana Cecilia Rodríguez, Mark Schiffman, Allan Hildesheim, Jorge Morales, Mario Alfaro, Diego Guillén, Martha L. Hutchinson, Mark E. Sherman, Claire Eklund, John Schussler, Julie Buckland, Lidia Ana Morera, Fernando Cárdenas, (unknown), (unknown), Thomas J. Cox, Robert D. Burk, Rolando Herrero	1
19	Population-Based Study of Human Papillomavirus Infection and Cervical Neoplasia in Rural Costa Rica 2000 ·Obstetrical & Gynecological Survey ·Rolando Herrero, Allan Hildesheim, (unknown), Mark E. Sherman, Martha L. Hutchinson, Jorge Morales, Ileana Balmaceda, Mitchell Greenberg, Mario Alfaro, Robert D. Burk, Sholom Wacholder, Martyn Plummer, Mark Schiffman	32
20	Reclassification of negative smears as atypical squamous cells of undetermined significance in quality assurance reviews 1999 ·Cancer ·Donald E. Stanley, (unknown), Mark E. Sherman	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact